Chemical Structure (Paroxetine 01)
Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 69367-337
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 69367-337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Paroxetine 02)
This is a list of various interacting drugs and their dosages. The drugs listed are Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin. The fold change and 90% CI are also provided, but it is unclear what they refer to without further context.*
Figure 2 (Paroxetine 03)
Figure 3 (Paroxetine 04)
Principal Display Panel (12.5 mg Tablet Bottle Label)
This is a medication called Paroxetine Extended Release Tablets, USP, which comes in a bottle of 30 tablets. Each tablet contains paroxetine hydrochloride equivalent to 12.5 mg paroxetine. It is important to refer to the accompanying prescribing information for the usual dosage. The medication should be stored at 25°C (77°F) with excursions permitted from 15° to 30°C (59° to 86°F) as per USP Controlled Room Temperature guidelines. It is advisable to use safety closures when dispensing the medication, unless otherwise directed by the physician or requested by the purchaser. The manufacturer, Visum Pharmaceuticals Co., Ltd, is based in Haikou, Hainan, China, while the distributor, Westminster Pharmaceuticals LLC, is in Nashville, TN. Children should be kept away from the medication.*
Principal Display Panel (25 mg Tablet Bottle Label)
NDC 69367-336-30 is a medication known as Paroxetine Extended-Release Tablets, USP manufactured by Visum Pharmaceutical in China and distributed by Westminster Pharmaceuticals. Each extended-release tablet contains 25g of paroxetine hydrochloride. It is recommended to store the tablets at room temperature, with safety closures in place. The package comes with medication guides specific to each patient. It is important to keep this product and all drugs out of reach of children.*
Principal Display Panel (37.5 mg Tablet Bottle Label)
This is the product label for Paroxetine Extended-Release Tablets, USP with NDC 69367-337-30. Each of the extended-release tablets contains 375 mg Paroxetine Hydrochloride. The drug is dispensed with medication guide provided separately to each patient. The usual dosage is mentioned in the accompanying prescribing information. The medication should be stored within 15° to 30°C (59° to 86°F) temperature range, and safety closures should be used while dispensing to ensure product safety. It emphasizes the importance of keeping this and all other drugs out of the reach of children. Manufactured by Visum Pharmaceutical Co. Ltd. in Hainan, China, and distributed by Westminster Pharmaceuticals LLC, in Nashville, TN.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
